SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Characterisation of digital therapeutic clinical trials: a systematic review with natural language processing
5 references·5 citing·35 second hop
Characterisation of digital therapeutic clinical trials: a systematic review with natural language processing (2024)Characterisation of digital therapeutic c…Open challenges in developing digital therapeutics in the United States (2022)Open challenges in developing…Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance (2022)Digital Therapeutics in Persp…A framework for digital health equity (2022)A framework for digital healt…Characteristics and challenges of the clinical pipeline of digital therapeutics (2020)Characteristics and challenge…Making Neighborhood-Disadvantage Metrics Accessible — The Neighborhood Atlas (2018)Making Neighborhood-Disadvant…Digital Therapeutics in China: Comprehensive Review (2025)Digital Therapeutics in China…Assessment of priorities, quality, and inclusivity of digital therapeutics trials in China (2025)Assessment of priorities, qua…Assessment of digital therapeutics in decentralized clinical trials: A scoping review (2025)Assessment of digital therape…Mapping the Evidence Supporting Digital Therapeutics (2024)Mapping the Evidence Supporti…Digital therapeutics in Korea: current status, challenges, and future directions – a narrative review (2024)Digital therapeutics in Korea…Social Conditions as Fundamental Causes of Disease (1995)Social Conditions As Fundamental Causes of Disease (1995)Adjusting for social risk factors impacts performance and penalties in the hospital readmissions reduction program (2019)County-level Social Vulnerability is Associated With Worse Surgical Outcomes Especially Among Minority Patients (2020)Risks of mental health outcomes in people with covid-19: cohort study (2022)Reimbursement of Apps for Mental Health: Findings From Interviews (2019)Insights into insurance coverage for digital therapeutics: A qualitative study of US payer perspectives (2024)Navigating the future of health care with AI-driven digital therapeutics (2024)The New Emerging Treatment Choice for Major Depressive Disorders: Digital Therapeutics (2024)Digital Therapeutics: An Integral Component of Digital Innovation in Drug Development (2018)Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical Pharmacology (2023)Exploring the potential of digital therapeutics: An assessment of progress and promise (2024)Self-efficacy: Toward a unifying theory of behavioral change. (1977)Self-efficacy: Toward a unifying theory of behavioral change. (1977)Self-efficacy mechanism in human agency. (1982)Digital divide as a determinant of health in the U.S. older adults: prevalence, trends, and risk factors (2024)Navigating the digital world: development of an evidence-based digital literacy program and assessment tool for youth (2024)Recommendations to advance digital health equity: a systematic review of qualitative studies (2024)Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrials.gov (2024)Medical big data: promise and challenges (2017)The efficacy of smartphone‐based mental health interventions for depressive symptoms: a meta‐analysis of randomized controlled trials (2017)Clinical review of user engagement with mental health smartphone apps: evidence, theory and improvements (2018)Developing and Evaluating Guidelines to Prevent Overdependence on Digital Therapeutics in Children and Adolescents: Randomized Controlled Trial (2025)Digital Therapeutics for Cognitive Impairment: Exploring Innovations, Challenges, and Future Prospects (2025)International Organization for Standardization (2011)Assessing risk of bias in a randomized trial (2019)Digital Mental Health Interventions for Depression, Anxiety, and Enhancement of Psychological Well-Being Among College Students: Systematic Review (2019)Role of digital therapeutics and the changing future of healthcare (2020)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Digital therapeutics from bench to bedside (2023)Scoping studies: towards a methodological framework (2005)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)Exploring new digital therapeutics technologies for psychiatric disorders using BERTopic and PatentSBERTa (2022)Assessing Patient Adherence to and Engagement With Digital Interventions for Depression in Clinical Trials: Systematic Literature Review (2023)Mapping Factors That Affect the Uptake of Digital Therapeutics Within Health Systems: Scoping Review (2023)
this work references cited by second hop

References

  • 2018Making Neighborhood-Disadvantage Metrics Accessible — The Neighborhood Atlas3,307 cited
  • 2022A framework for digital health equity600 cited
  • 2020Characteristics and challenges of the clinical pipeline of digital therapeutics142 cited
  • 2022Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance38 cited
  • 2022Open challenges in developing digital therapeutics in the United States32 cited

Cited by

  • 2024Digital therapeutics in Korea: current status, challenges, and future directions – a narrative review15 cited
  • 2025Digital Therapeutics in China: Comprehensive Review9 cited
  • 2024Mapping the Evidence Supporting Digital Therapeutics7 cited
  • 2025Assessment of digital therapeutics in decentralized clinical trials: A scoping review4 cited
  • 2025Assessment of priorities, quality, and inclusivity of digital therapeutics trials in China3 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work